Fostair
Client: Chiesi
Client: Chiesi
about the project...
Chiesi Farmaceutici S.p.A. is an international pharmaceutical company with origins in Parma, Italy. Today it has global operations in all 5 continents and has 3 manufacturing plants and 4 research centres.
One of its key branded drugs is the Fostair Asthma treatment which is sold in over 30 countries worldwide.
One of its key branded drugs is the Fostair Asthma treatment which is sold in over 30 countries worldwide.
motion gfx
Fostair, a combination drug consisting of a long-acting bronchodilator and a steroid, has been developed in order to provide innovative treatment in respiratory medicine
Fostair's USP is its extra-fine formulation based on Modulite technology. The Modulite spray, which is able to release the active ingredient as extra-fine particles, guarantees an even distribution of the drug throughout the entire bronchial tree, thus ensuring uniform treatment of inflammation and bronchoconstriction in the central and peripheral airways.
Eon Visual Media has produced a sequence of motion graphics to demonstrate how Fostair's Modulite technology works when used by asthama sufferers. This gfx sequence is used by both Doctors and patients in understanding how the the treatment works.
Fostair's USP is its extra-fine formulation based on Modulite technology. The Modulite spray, which is able to release the active ingredient as extra-fine particles, guarantees an even distribution of the drug throughout the entire bronchial tree, thus ensuring uniform treatment of inflammation and bronchoconstriction in the central and peripheral airways.
Eon Visual Media has produced a sequence of motion graphics to demonstrate how Fostair's Modulite technology works when used by asthama sufferers. This gfx sequence is used by both Doctors and patients in understanding how the the treatment works.